1. Home
  2. IMNM vs HTBK Comparison

IMNM vs HTBK Comparison

Compare IMNM & HTBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • HTBK
  • Stock Information
  • Founded
  • IMNM 2006
  • HTBK 1997
  • Country
  • IMNM United States
  • HTBK United States
  • Employees
  • IMNM N/A
  • HTBK N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • HTBK Major Banks
  • Sector
  • IMNM Health Care
  • HTBK Finance
  • Exchange
  • IMNM Nasdaq
  • HTBK Nasdaq
  • Market Cap
  • IMNM 747.7M
  • HTBK 612.3M
  • IPO Year
  • IMNM 2020
  • HTBK 1998
  • Fundamental
  • Price
  • IMNM $12.09
  • HTBK $10.00
  • Analyst Decision
  • IMNM Strong Buy
  • HTBK Buy
  • Analyst Count
  • IMNM 4
  • HTBK 3
  • Target Price
  • IMNM $28.75
  • HTBK $11.50
  • AVG Volume (30 Days)
  • IMNM 761.5K
  • HTBK 377.4K
  • Earning Date
  • IMNM 11-07-2024
  • HTBK 10-24-2024
  • Dividend Yield
  • IMNM N/A
  • HTBK 5.26%
  • EPS Growth
  • IMNM N/A
  • HTBK N/A
  • EPS
  • IMNM N/A
  • HTBK 0.79
  • Revenue
  • IMNM $10,784,000.00
  • HTBK $174,590,000.00
  • Revenue This Year
  • IMNM N/A
  • HTBK N/A
  • Revenue Next Year
  • IMNM N/A
  • HTBK $6.71
  • P/E Ratio
  • IMNM N/A
  • HTBK $12.52
  • Revenue Growth
  • IMNM 62.73
  • HTBK N/A
  • 52 Week Low
  • IMNM $6.93
  • HTBK $7.66
  • 52 Week High
  • IMNM $30.96
  • HTBK $10.99
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 36.69
  • HTBK 58.68
  • Support Level
  • IMNM $11.81
  • HTBK $9.44
  • Resistance Level
  • IMNM $12.44
  • HTBK $9.89
  • Average True Range (ATR)
  • IMNM 0.68
  • HTBK 0.21
  • MACD
  • IMNM -0.11
  • HTBK 0.04
  • Stochastic Oscillator
  • IMNM 11.61
  • HTBK 99.17

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two segments, namely Banking and Factoring. The bank generates its revenue from the Banking segment.

Share on Social Networks: